284 related articles for article (PubMed ID: 32699361)
1. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.
Parvez S; Yadagiri G; Gedda MR; Singh A; Singh OP; Verma A; Sundar S; Mudavath SL
Sci Rep; 2020 Jul; 10(1):12243. PubMed ID: 32699361
[TBL] [Abstract][Full Text] [Related]
2. Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system.
Parvez S; Yadagiri G; Singh A; Karole A; Singh OP; Sundar S; Mudavath SL
Chem Phys Lipids; 2020 Sep; 231():104946. PubMed ID: 32621810
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
[TBL] [Abstract][Full Text] [Related]
4. Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles.
Parvez S; Yadagiri G; Arora K; Javaid A; Kushwaha AK; Singh OP; Sundar S; Mudavath SL
ACS Biomater Sci Eng; 2023 Jun; 9(6):2902-2910. PubMed ID: 34463477
[TBL] [Abstract][Full Text] [Related]
5. Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity.
Parvez S; Yadagiri G; Karole A; Singh OP; Verma A; Sundar S; Mudavath SL
Front Cell Infect Microbiol; 2020; 10():570573. PubMed ID: 33178626
[TBL] [Abstract][Full Text] [Related]
6. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
Tripathi P; Jaiswal AK; Dube A; Mishra PR
Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
Afzal I; Sarwar HS; Sohail MF; Varikuti S; Jahan S; Akhtar S; Yasinzai M; Satoskar AR; Shahnaz G
Nanomedicine (Lond); 2019 Feb; 14(4):387-406. PubMed ID: 30688557
[TBL] [Abstract][Full Text] [Related]
8. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
[TBL] [Abstract][Full Text] [Related]
9. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
[TBL] [Abstract][Full Text] [Related]
10. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
[TBL] [Abstract][Full Text] [Related]
12. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion.
Rochelle do Vale Morais A; Silva AL; Cojean S; Balaraman K; Bories C; Pomel S; Barratt G; do Egito EST; Loiseau PM
Exp Parasitol; 2018 Sep; 192():85-92. PubMed ID: 30075233
[TBL] [Abstract][Full Text] [Related]
14. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
[TBL] [Abstract][Full Text] [Related]
15. Current scenario of drug development for leishmaniasis.
Croft SL; Seifert K; Yardley V
Indian J Med Res; 2006 Mar; 123(3):399-410. PubMed ID: 16778319
[TBL] [Abstract][Full Text] [Related]
16. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
Seifert K; Croft SL
Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutics of visceral leishmaniasis: present and future developments.
Sundar S; Singh A
Parasitology; 2018 Apr; 145(4):481-489. PubMed ID: 29215329
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B
Singh A; Yadagiri G; Parvez S; Singh OP; Verma A; Sundar S; Mudavath SL
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111279. PubMed ID: 32919641
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.
Mbongo N; Loiseau PM; Craciunescu DG; Robert-Gero M
Acta Trop; 1998 Jun; 70(2):239-45. PubMed ID: 9698271
[No Abstract] [Full Text] [Related]
[Next] [New Search]